Blood markers (sFlt-1/PlGF, sEng, OPG) for diagnosing and monitoring preeclampsia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort will enroll pregnant women at 20–36 weeks and collect blood samples to measure the sFlt-1/PlGF ratio, sEng, and OPG. Biomarker levels will be compared with clinical signs (blood pressure, proteinuria, and other maternal organ dysfunction) and timing of any preeclampsia diagnosis. Participants will be followed through delivery to record maternal and perinatal outcomes and treatments received. The aim is to see if these markers improve diagnostic accuracy or monitoring compared with standard clinical criteria.

Why it matters

Who can join: the full rules

IInclusion Criteria:

* Pregnant women between 20 and 36 weeks of gestation
* Age between 18 and 45 years
* Attending the antenatal clinic at the study site

Exclusion Criteria:

* Chronic hypertension
* Renal disease
* Diabetes mellitus
* Multiple gestations
* Autoimmune disorders

Where it's running

• Bint Al Huda Maternity Hospital
  Nasiriyah, Dhi Qar, Iraq Recruiting

Study contacts

• Study coordinator: Ammar Jassim Abed, MSc
• Email: ammar.jassim11@gmail.com
• Phone: +9647809561105

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Atorvastatin after pregnancy to lower future heart disease risk

  This study will test whether taking atorvastatin for three months after stopping breastfeeding lowers future cardiovascular risk in people who had high blood pressure during pregnancy.

  Recruiting Phase 4 Ohio State University · Columbus, Ohio · NCT06632379

• Comparing two doses of aspirin to prevent pregnancy-related high blood pressure issues

  This study is testing if a higher dose of aspirin can better prevent high blood pressure problems during pregnancy for women at risk.

  Recruiting at 15 sites Phase 4 Ohio State University · Birmingham, Alabama and 19 other locations · NCT06468202

• MH-Rx: Check-in on You, Your Medication, and Your Blood Pressure for Pregnant People

  This trial tests whether adding virtual social-support and medication management to remote blood pressure monitoring helps pregnant people with chronic or gestational hypertension.

  Recruiting Texas Southern University · Houston, Texas · NCT07842341

• Community health worker support to lower blood pressure after pregnancy with high blood pressure

  Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT07778966

• Endothelial Biomarkers in Pregnancy: Endothelial Extracellular Vesicles and Hypertensive Disorders

  This study tests whether endothelial extracellular vesicles in the blood differ between normotensive pregnant women and those with hypertensive disorders of pregnancy.

  Recruiting Josip Juraj Strossmayer University of Osijek · Osijek · NCT07728656

• Aspirin with or without low‑molecular‑weight heparin to prevent preeclampsia in high‑risk pregnancy

  This trial tests whether adding low‑molecular‑weight heparin (tinzaparin) to low‑dose aspirin reduces the chance of preeclampsia in pregnant people identified as high risk in the first trimester.

  Recruiting Phase 4 Alexandra Hospital, Athens, Greece · Athens, Attica · NCT07361679

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.